The authors reported 1,3-dicaffeoylquinic acid as potent inhibitor of 14-3-3τ protein, thus preventing breast cancer proliferation and metastasis via Jak/PI3K/Akt and Raf/ERK pathway. This evidence concerns the gene AKT1 and breast carcinoma.